Background and Purpose—The purpose of these guidelines is to provide an up-to-date
comprehensive set of recommendations in a single document for clinicians caring for adult …

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A
Guideline for Healthcare Professionals From the American Heart Association/American Stroke …

Background and Purpose—There are scarce data regarding the safety of intravenous
thrombolysis (IVT) in acute ischemic stroke among patients on direct oral anticoagulants …

Inflammation plays a pivotal role in the pathogenesis of ischemic stroke. The inhibition of
inflammation appears to be a potential therapeutic strategy for neuro-inflammatory injury …

Objective Increased blood pressure (BP) management following acute ischemic stroke (AIS)
remains controversial. This study aimed to identify the association between BP and clinical …

Background/Aims: Ischemic stroke results in increased cerebral infarction, neurological
deficits and neuroinflammation. The underlying mechanisms involving the anti-inflammatory …

Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute
Ischemic Stroke in the Emergency Department - Annals of Emergency Medicine Skip to Main …

Elucidating action mechanisms of Chinese medicines has remained a challenging task due
to the chemical and biological complexity that needs to be resolved. In this study we applied …

Purpose: Several clinical trials have highlighted general favorable outcomes of intravenous
tissue type plasminogen activator (rt-PA) in acute ischemic stroke using different measures …

Background: The NINDS trial demonstrated the efficacy of intravenous (IV) recombinant
tissue plasminogen activator (rtPA) in improving the neurologic outcome in patients …